News

Par began shipping 0.25mg/2ml and 0.5mg/2ml to the trade. Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months

The primary objective of this Phase II study is to evaluate the antitumor activity of the combination of capecitabine and lapatinib with and without IMC-A12 in patients with

The study achieved statistical and clinical significance in its primary efficacy endpoint. Patients receiving the combination of twice-daily mitiglinide and metformin experienced a statistically significant additional reduction in

Frazier Healthcare Ventures and Alta Partners co-led the $16.7 million tranche, which also included existing investors Burrill & Company, Three Arch Partners, and Altitude Life Science Ventures. This

The trial is designed to include approximately 212 patients with stable schizophrenia who are receiving atypical antipsychotic therapy. Subjects in the study are randomized to receive 5mg, 15mg

The multi-center, randomized, double-blinded, placebo-controlled study evaluated the safety and efficacy of the company’s 3% diclofenac diethanolamine NanoEmulsion cream in 104 patients with chronic pain due to osteoarthritis

Shipment of these products has commenced. Teva is currently involved in patent litigation concerning this product in the US District Court of New Jersey. A trial has been

The approval follows the recent release of the Epic clinical study data demonstrating the lowest stroke rates of any filter currently available on the US market. The FiberNet

Interim data has demonstrated an approximately 25% lower risk of death in the TNFerade plus standard of care (SOC) arm relative to the SOC alone (Hazard Ratio= 0.753;